Clinical Trials Logo

Clinical Trial Summary

Effectiveness: The purpose of this study is to demonstrate the non-inferiority of Radiesse (CaHA) to Restylane (HA) following subdermal implantation for the correction of moderate to severe facial wrinkles and folds, such as NLFs. Safety: To evaluate the incidence and type of adverse events and serious adverse events.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Correction of Moderate to Severe Nasolabial Folds (NLFs)

NCT number NCT04647721
Study type Interventional
Source Merz North America, Inc.
Contact
Status Completed
Phase N/A
Start date January 13, 2021
Completion date April 27, 2022